|
|
| (One intermediate revision by the same user not shown) |
| Line 1: |
Line 1: |
| − | The International Federation of Pharmaceutical Manufacturers Associations (IFPMA) was established in 1968<ref>International Federation of Pharmaceutical Manufacturers Associations [http://www.ifpma.org/About_Us/about_mission.aspx Mission] Accessed 11th March 2008</ref> and describes itself as<ref>International Federation of Pharmaceutical Manufacturers Associations [http://www.ifpma.org/About_Us/about.aspx About IFPMA] Accessed 11th March 2008</ref> 'a non-profit, non-governmental Organization (NGO) representing national industry associations and companies from both developed and developing countries'. Its members consists of companies in areas of research-based pharma-ceutical, biotech and vaccine.
| + | see [[International Federation of Pharmaceutical Manufacturers and Associations]] |
| − | | |
| − | The main objectives of IFPMA are described as being 'to encourage a global policy environment that is conducive to innovation in medicine', to 'foster collaborative relationships and partnerships with international organizations, national institutions, governments and non-governmental organizations' and to coordinate its members efforts and share experience<ref>ibid</ref>.
| |
| − | | |
| − | ==Members==
| |
| − | In October 2003, IFPMA lists the following members<ref>International Federation of Pharmaceutical Manufacturers Associations [http://www.ifpma.org/About_Us/about_mem_europe.aspx Members] Accessed 11th March 2008</ref>
| |
| − | | |
| − | * [[Abbott Laboratories]]
| |
| − | * [[Almirall-Prodesfarma]]
| |
| − | * [[Astellas Pharma]]
| |
| − | * [[AstraZeneca]]
| |
| − | * [[Bayer]] Healthcare
| |
| − | * [[Boehringer Ingelheim]]
| |
| − | * [[Bristol-Myers Squibb]]
| |
| − | * [[Chugai Pharmaceutical]]
| |
| − | * [[Eisai]]
| |
| − | * [[Eli Lilly and Company]]
| |
| − | * [[Esteve]]
| |
| − | * [[F Hoffmann-La Roche]]
| |
| − | * [[GlaxoSmithKline]]
| |
| − | * [[Merck]] & Co.
| |
| − | * [[Merck]] KGaA
| |
| − | * [[Menarini]]
| |
| − | * [[Novartis]]
| |
| − | * [[Nicholas Piramal India]]
| |
| − | * [[Pfizer]]
| |
| − | * [[Sanofi-Aventis]]
| |
| − | * [[Schering-Plough]]
| |
| − | * [[Servier I.R.I.S.]]
| |
| − | * [[Sigma-Tau]]
| |
| − | * [[Takeda Pharmaceutical]]
| |
| − | * [[Wyeth]]
| |
| − | | |
| − | ==People==
| |
| − | In 2008, the IFPMA list the following Council members<ref>International Federation of Pharmaceutical Manufacturers Associations [http://www.ifpma.org/About_Us/about_council.aspx Council] Accessed 11th March 2008</ref>...
| |
| − | | |
| − | ===President===
| |
| − | * [[Fred Hassan]] (USA) - Chairman & Chief Executive Officer of the [[Schering-Plough]] Corporation. Hassan was previously chairman of the Board of Directors of the [[Pharmaceutical Research and Manufacturers of America]] (PhRMA) and chairman of the [[HealthCare Institute of New Jersey]]. Haasan has also in the past worked for [[Wyeth]] and [[Sandoz Pharmaceuticals]] (now [[Novartis]]).
| |
| − | | |
| − | ===Vice Presidents===
| |
| − | * [[Alessandro Banchi]] (Germany) - Chairman of the Board of Managing Directors for [[Boehringer Ingelheim]].
| |
| − | * [[Haruo Naito]] (Japan) - President and Chief Executive Officer of [[Eisai]] Co. Ltd.
| |
| − | | |
| − | ===Council Members===
| |
| − | * [[Miles D White]] (USA) - Chairman of the Board & CEO with [[Abbott Laboratories]]
| |
| − | * [[Jorge Gallardo]] (Spain) - President of [[Almirall]]
| |
| − | * [[Hatsuo Aoki]] (Japan) - Representative Director & Chairman of [[Astellas Pharma Inc.]]
| |
| − | * [[Arthur Higgins]] (Germany) - Chairman, Executive Committee of [[Bayer]] Healthcare AG
| |
| − | * [[Lamberto Andreotti]] (USA) - Executive Vice President & President, Worldwide Pharmaceuticals for [[Bristol-Myers Squibb]]
| |
| − | * [[Antoni Esteve]] (Spain) - Executive Committee Member for [[Esteve]]
| |
| − | * [[William Burns]] (Switzerland) - Chief Executive Officer, Pharmaceuticals Division with [[F Hoffmann-La Roche Ltd]].
| |
| − | * [[Jean-Pierre Garnier]] (USA) - Chief Executive Officer for [[GlaxoSmithKline]]
| |
| − | * [[Alberto Aleotti]] (Italy) - President & Chairman of [[Menarini]] SA
| |
| − | * [[Richard T Clark]] (USA) - Chairman, President & CEO of [[Merck]] & Co., Inc.
| |
| − | * [[Elmar J Schnee]] (Germany) - General Partner & Deputy Member of the Executive Board of [[Merck]] KGaA
| |
| − | * [[Daniel Vasella]] (Switzerland) - Chairman & Chief Executive Officer of [[Novartis]] International AG
| |
| − | * [[Toon Wilderbeek]] - (The Netherlands) - President of [[N V Organon]]
| |
| − | * [[Jeffrey B Kindler]] (USA) - Chairman & CEO of [[Pfizer]] Inc.
| |
| − | * [[Philippe Peyre]] (France) - Senior Vice-President, Affaires Générales with [[Sanofi-Aventis]]
| |
| − | * [[Rafael Gual Cosio]] (Latin America) - Executive Director of [[Asociación Mexicana de Industrias de Investigación Farmacéutica]] A.C. (AMIIF) & [[Federación Latinoamericana de la Industria Farmacéutica]] (FIFARMA)
| |
| − | * [[Gabriel Tannus]] (Brazil) - Executive President of [[INTERFARMA]]
| |
| − | * [[Jeff Schultz]] (Republic of China) - Managing Director of the [[R&D-based Pharmaceutical Association in China]]
| |
| − | * [[Bernard Lemoine]] (France) - Executive President of [[Les Entreprises du Médicament]] (LEEM)
| |
| − | * [[Cornelia Yzer]] (Germany) - Director General with [[Verband Forschender Arzneinmittelhersteller]] (VFA)
| |
| − | * [[Tapan Ray]] (India) - Director General of [[Organisation of Pharmaceutical Producers of India]] (OPPI)
| |
| − | * [[Claudio Cavazza]] (Italy) - Board Member of [[Farmindustria]]
| |
| − | * [[Kazutaka Ichikawa]] (Japan) - Director General of [[Japan Pharmaceutical Manufacturers Association]] (JPMA)
| |
| − | * [[Keh Song Hock]] (Malaysia) - Executive Director of [[Pharmaceutical Association of Malaysia]] (PhAMA)
| |
| − | * [[Pal Christian Roland]] (Norway) - Director General of [[Legemiddelindustriforeningen]] (LMI)
| |
| − | * [[Michel Dutrée]] (The Netherlands) - General Manager of [[NEFARMA]]
| |
| − | * [[Vladimir Shipkov]] (Russian Federation) - Executive Director of [[AIPM]]
| |
| − | * [[Fok Tai Hung]] (Singapore) - Executive Director of [[Singapore Association of Pharmaceutical Industries]] (SAPI)
| |
| − | * [[Vicki Ehrich]] (South Africa) - Chief Operating Officer of the [[Pharmaceutical Industry Association of South Africa]] (PIASA)
| |
| − | * [[Humberto Arnés Corellano]] (Spain) - Director General of [[FARMAINDUSTRIA]]
| |
| − | * [[Richard Bergström]] (Sweden) - Director General of the [[Swedish Association of the Pharmaceutical Industry]] (LIF)
| |
| − | * [[Thomas Cueni]] (Switzerland) - Secretary General of [[INTERPHARMA]]
| |
| − | * [[Engin Güner]] (Turkey) - Secretary General of [[Turkey's Association of Research-based Pharmaceutical Companies]] (AIFD)
| |
| − | * [[Richard Barker]] (UK) - Director General of [[Association of the British Pharmaceutical Industry]] (ABPI)
| |
| − | * [[Billy Tauzin]] (USA) - President & Chief Executive Officer of [[Pharmaceutical Research and Manufacturers of America]] (PhRMA)
| |
| − | | |
| − | ==References==
| |
| − | <references/>
| |
| − | | |
| − | [[Category:Pharmaceutical Industry]]
| |
| − | [[Category:Lobbying firms]]
| |
